Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer

Leah L Thompson; Jaewon Yoon; Nira A Krasnow; Michael S Chang; Edward B Li; Devon E McMahon; Steven T Chen

doi:10.1001/jamadermatol.2021.0727

Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer

JAMA Dermatol. 2021 Apr 14;157(5):599-602. doi: 10.1001/jamadermatol.2021.0727. Online ahead of print.

Authors

Leah L Thompson¹, Jaewon Yoon¹, Nira A Krasnow¹, Michael S Chang¹, Edward B Li¹, Devon E McMahon¹, Steven T Chen¹

Affiliation

¹ Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Abstract

This cohort study investigates the association of systemic corticosteroid exposures with infectious complications and survival outcomes among patients with a cutaneous immune-related adverse event.